Cochrane · systematic review · CD001511

Glucocorticosteroids for people with alcoholic hepatitis

Pavlov, CS, Varganova, DL, Casazza, G, et al. · Cochrane Database of Systematic Reviews · 2019 · Cochrane Library

Hepato-Biliary2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
6
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 5 · 83.3%Low 1 · 16.7%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Show all 2 versions

Glucocorticosteroids for people with alcoholic hepatitis

Population: participants with alcoholic hepatitis at high risk of mortality and morbidity
6 questions
OutcomeEffectEvidenceStatus / GRADE
All‐cause mortality: up to 3 months'
RR 0.9 [0.7, 1.15]15 studies · 1861 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Health‐related quality of life: up to 3 months (
no estimate extracted1 study · 377 participantsLow
Downgraded: risk of bias, imprecision
Serious adverse events during treatment
RR 1.05 [0.85, 1.29]15 studies · 1861 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Liver‐related mortality: up to 3 months'
RR 0.89 [0.69, 1.14]15 studies · 1861 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Participants with any complication: up to 3 months following randomisation
RR 1.04 [0.86, 1.27]15 studies · 1861 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Participants with non‐serious adverse events: up to 3 months'
RR 1.99 [0.72, 5.48]4 studies · 160 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, publication bias